Corcept 制药 CORT
$72.77 +$1.14 (+1.59%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $72.77 0.00%
开盘$73.60
昨收$71.63
当日区间$72.17 – $74.86
成交量1.41M
市值$7.96B
市盈率（TTM）54.7
股息率–
CORT 相关新闻
匹配 Corcept Therapeutics 或代码 CORT 的头条新闻，按最新排序。
- H.C. Wainwright Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $165
- Form 144 | Corcept Therapeutics(CORT.US) Director Proposes to Sell 3.34 Million in Common Stocks
- Corcept Therapeutics(CORT.US) Officer Sells US$3.89 Million in Common Stock
- Piper Sandler Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $165
- Corcept Therapeutics(CORT.US) Director Sells US$12.25 Million in Common Stock
- Truist Financial Initiates Corcept Therapeutics(CORT.US) With Buy Rating, Announces Target Price $164
- CCORF Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $161
- CCORF Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $135
- H.C. Wainwright Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Raises Target Price to $165 正面
- Piper Sandler Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Raises Target Price to $165 正面
- Wolfe Research Maintains Corcept Therapeutics(CORT.US) With Sell Rating, Maintains Target Price $50
- CCORF Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Raises Target Price to $161 正面
- Wolfe Research Downgrades Corcept Therapeutics(CORT.US) to Sell Rating, Announces Target Price $50 负面
- H.C. Wainwright Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $95
- Piper Sandler Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $88
暂无评论——快来第一个聊聊 CORT。